|
|
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Jean-Luc Harousseau
,
Herve Avet-Loiseau
,
Michel Attal
,
Catherine Charbonnel
,
Frederic Garban
et al.
Journal articles
hal-00821143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Philippe Moreau
,
Frédéric Garban
,
Michel Attal
,
Mauricette Michallet
,
Gérald Marit
et al.
Journal articles
hal-00821148v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
Gandhi Damaj
,
Alain Duhamel
,
Marie Robin
,
Yves Beguin
,
Mauricette Michallet
et al.
Journal articles
inserm-00821506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Claire Fabre
,
Serge Koscielny
,
Mohamad Mohty
,
Nathalie Fegueux
,
Didier Blaise
et al.
Journal articles
hal-00849621v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Disease status and stem cell source impact on the results of reduced intensity conditioning transplant for Hodgkin lymphoma: a retrospective study from the French Society of Bone Marrow Graft Transplantation and Cellular Therapy.
Ambroise Marcais
,
Raphael Porcher
,
Marie Robin
,
Mohamad Mohty
,
Mauricette Michalet
et al.
Journal articles
hal-00821128v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|